Autopsy report · NCT04255446
Structured Light Plethysmography Against Standard of Care in the Diagnosis and Monitoring of Dysfunctional Breathing
Cause of deathRegulatory or ethics
“Study terminated/withdrawn due to the prolonged timeline since initial ethical approval (without starting) and the number of significant changes to the management and structure of the study deemed appropriate for continuation due to the delays.”
Life of this trial
- Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.
Vital statistics
- Status
- Withdrawn
- Sponsor
- Pneumacare Ltd
- Sponsor type
- Industry
- Conditions
- Dysfunctional Breathing
- Interventions
- Thora3DiTM
- Participants
- 0
- Sites
- 1
- Countries
- United Kingdom
Trials that died the same way
- Integrative Liver-Targeted Therapy for Diabetic Macular Edema: Using "Tauroursodeoxycholate" or Traditional Chinese Medicine.
“The study was terminated due to additional regulatory requirements that could not be completed within the established academic timeline. As a result, continuation of the study was not feasible.” - Safety, Pharmacokinetics and Efficacy Study of QCC374 in PAH Patients
“Study was terminated early for strategic reasons. Only Part I of the study was completed.” - Adherence to Antidepressant Treatment in Subjects With Depression
“The study was terminated early based on the planned interim analysis that did not meet criteria for continuation.” - Leronlimab (PRO 140) Combined With Carboplatin in Patients With Cytokine Chemokine Receptor 5 Positive (CCR5+) mTNBC
“Study terminated prematurely due to business reasons. Participants are no longer examined or receiving intervention.” - LMB-100 Followed by Pembrolizumab in the Treatment of Adults With Mesothelin-Expressing Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
“Study was terminated due to slow accrual.”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.